search
Back to results

Abuse Liability of Reduced Nicotine Content Cigarettes Within a Complex Tobacco Marketplace

Primary Purpose

Substance-Related Disorders

Status
Completed
Phase
Not Applicable
Locations
United States
Study Type
Interventional
Intervention
SPECTRUM cigarettes
SPECTRUM cigarettes between
Sponsored by
Virginia Polytechnic Institute and State University
About
Eligibility
Locations
Arms
Outcomes
Full info

About this trial

This is an interventional basic science trial for Substance-Related Disorders

Eligibility Criteria

18 Years - 65 Years (Adult, Older Adult)All SexesAccepts Healthy Volunteers

Inclusion Criteria:

  • smoke at least 5 cigarettes per day
  • have a breath carbon monoxide (CO) level of at least 10 ppm at intake
  • no immediate plans to quit smoking.

Exclusion Criteria:

  • pregnant, lactating, plans to become pregnant
  • weigh more than 110lbs (experiment 1 only)
  • have plans to move out of the area during the course of the experiment

To see if you are eligible, use the following confidential link: http://vtcri.info/arrcclinicaltrials

Sites / Locations

  • Fralin Biomedical Research Institute at VTC

Arms of the Study

Arm 1

Arm 2

Arm 3

Arm 4

Arm 5

Arm 6

Arm Type

Experimental

Experimental

Experimental

Experimental

Experimental

Experimental

Arm Label

Single arm

0.4 mg/g Concentration

1.3 mg/g Concentration

2.4 mg/g Concentration

5.2 mg/g Concentration

15.8 mg/g Concentration

Arm Description

All participants will complete the same experimental events across 6 laboratory sessions.

Participants in this arm will experience the 0.4 mg/g Concentration

Participants in this arm will experience the 1.3 mg/g Concentration

Participants in this arm will experience the 2.4 mg/g Concentration

Participants in this arm will experience the 5.2 mg/g Concentration

Participants in this arm will experience the 15.8 mg/g Concentration

Outcomes

Primary Outcome Measures

Estimated Cigarettes Taken at Free Price Derived From the Cigarette Purchase Task
The Cigarette Purchase Task is a behavioral economic measure of abuse liability that consists of a series of hypothetical questions asking participants to indicate how many cigarettes they would purchase for their own consumption across a range of cigarette prices. Participants smoked one cigarette and then were asked to report how many cigarettes they would smoke within a 24 hour period at the following prices: $0.00 (free), $0.01, $0.05, $0.10, $0.25, $0.50, $1, $2, $5, $10, $25, $50, $100, $200. Nonlinear regression was then used to estimate the number of cigarettes participants would take when they were free using the equation by Koffarnus et al. (2015; doi:10.1037/pha0000045). The outcome is the logarithmically transformed number of cigarettes.
Change in Blood Nicotine Content Over the Course of the Session
For participants in the single arm only, blood will be collected throughout each session and analyzed for nicotine content. The change in blood nicotine content over the course of the session will be compared among the six sessions where different cigarettes were administered. Blood nicotine (expressed in ng/mL) at minute 0 was subtracted from blood nicotine at minutes 10, 15, 20, 30, 45, and 60 to yield a change in blood nicotine (negative values were truncated to 0) at each of the time points. Using these change in blood nicotine values, we calculated Area Under the Curve (AUC) via the trapezoidal rule, which resulted in a singular number (total change in blood nicotine over the course of each experimental session) in our primary outcome measure.
Experimental Marketplace Purchases
In all arms except the single arm, measures of quantities of experimental cigarettes and other nicotine products will be obtained.

Secondary Outcome Measures

Full Information

First Posted
October 27, 2016
Last Updated
August 26, 2021
Sponsor
Virginia Polytechnic Institute and State University
Collaborators
University of Kentucky
search

1. Study Identification

Unique Protocol Identification Number
NCT02951143
Brief Title
Abuse Liability of Reduced Nicotine Content Cigarettes Within a Complex Tobacco Marketplace
Official Title
Abuse Liability of Reduced Nicotine Content Cigarettes Within a Complex Tobacco Marketplace
Study Type
Interventional

2. Study Status

Record Verification Date
August 2021
Overall Recruitment Status
Completed
Study Start Date
January 2017 (Actual)
Primary Completion Date
November 2019 (Actual)
Study Completion Date
November 2019 (Actual)

3. Sponsor/Collaborators

Responsible Party, by Official Title
Principal Investigator
Name of the Sponsor
Virginia Polytechnic Institute and State University
Collaborators
University of Kentucky

4. Oversight

Data Monitoring Committee
No

5. Study Description

Brief Summary
Tobacco regulatory policies can have unanticipated consequences; therefore, methods that would permit prospective estimates of the effects of potential tobacco regulations are necessary for the development of tobacco regulatory science. The goal of this project is to experimentally assess how smokers purchase and consume reduced-nicotine cigarettes. In experiment 1, we will investigate how purchasing/consuming reduced-nicotine cigarettes is related to nicotine content and absorption. In experiment 2, we will investigate how purchasing/consuming changes when other nicotine products are available in an experimental marketplace setting. The proposed projects can directly inform tobacco regulation by providing estimates of the real-world effects of novel policies.
Detailed Description
The specific objective in Experiment 1 is to examine the effect of nicotine content (0.4 mg/g, 1.4 mg/g, 2.5 mg/g, 5.6 mg/g, and 17.4 mg/g of tobacco) and blood nicotine absorption on laboratory behavioral economic measures of demand intensity and elasticity. Under double-blind conditions, we will examine the relationship between plasma nicotine and cigarette demand as a function of the dose of the nicotine in the cigarettes. Regular cigarette smokers will consume, on separate sessions, controlled puffs of a cigarette containing a blinded dose of nicotine then complete a cigarette purchase task, our measure of value, while plasma nicotine is measured. We hypothesize that cigarette demand will be associated with dose and level of circulating nicotine, but in a nonlinear fashion such that consumption of very low dose cigarettes will not be predicted by nicotine dose or intake alone. To inform how various products may interact, we have developed and tested a novel method called the Experimental Tobacco Marketplace. The Experimental Tobacco Marketplace is a systematic extension of similar marketplace methods used with other consumer products (e.g., food marketplaces used in obesity and other nutrition-related research; Epstein, Dearing, Roba, & Finkelstein, 2010). In experimental marketplaces, multiple products are available and the experimenter controls the prices for each. These marketplaces can be either physical or virtual stores (similar to online retailers) and permit the examination of demand elasticity and intensity and degree of substitution or complementarity in consumer behavior under conditions that approximate naturalistic settings. Experiment 2 will extend findings from the first experiment examining the effects of different concentrations of nicotine in cigarettes (0.4mg/g, 1.4mg/g, 2.5mg/g, 5.6mg/g, 17.4mg/g) and blood nictotine absorption on laboratory behavioral economic demand measures. Employing this innovative Experimental Tobacco Marketplace, we propose to examine reduced-nicotine cigarettes under the following conditions: 1) control conditions where lower dose nicotine cigarettes are the only available product in the Experimental Tobacco Marketplace and where the tobacco marketplace is similar to the current real-world marketplace (i.e., no lower dose nicotine cigarettes, but a variety of other tobacco products); 2) lower dose nicotine cigarettes are available with a number of other nicotine products excluding conventional cigarettes; and 3) lower dose nicotine cigarettes are available with a number of other nicotine products including conventional cigarettes.

6. Conditions and Keywords

Primary Disease or Condition Being Studied in the Trial, or the Focus of the Study
Substance-Related Disorders

7. Study Design

Primary Purpose
Basic Science
Study Phase
Not Applicable
Interventional Study Model
Parallel Assignment
Masking
ParticipantInvestigator
Allocation
Randomized
Enrollment
305 (Actual)

8. Arms, Groups, and Interventions

Arm Title
Single arm
Arm Type
Experimental
Arm Description
All participants will complete the same experimental events across 6 laboratory sessions.
Arm Title
0.4 mg/g Concentration
Arm Type
Experimental
Arm Description
Participants in this arm will experience the 0.4 mg/g Concentration
Arm Title
1.3 mg/g Concentration
Arm Type
Experimental
Arm Description
Participants in this arm will experience the 1.3 mg/g Concentration
Arm Title
2.4 mg/g Concentration
Arm Type
Experimental
Arm Description
Participants in this arm will experience the 2.4 mg/g Concentration
Arm Title
5.2 mg/g Concentration
Arm Type
Experimental
Arm Description
Participants in this arm will experience the 5.2 mg/g Concentration
Arm Title
15.8 mg/g Concentration
Arm Type
Experimental
Arm Description
Participants in this arm will experience the 15.8 mg/g Concentration
Intervention Type
Drug
Intervention Name(s)
SPECTRUM cigarettes
Intervention Description
Across six laboratory sessions, participants will consume 10 puffs of either their usual brand of cigarette (one session) or a SPECTRUM cigarette (five sessions) with a nicotine yield varying from 0.03 to 0.70 and either menthol (TPMF codes NRC 103, NRC 201, NRC 301, NRC 401, and NRC 601) or tobacco (TPMF codes NRC 102, NRC 200, NRC 300, NRC 400, and NRC 600) flavor, depending on preference. This will be followed by the collection of blood nicotine content and a cigarette purchase task.
Intervention Type
Drug
Intervention Name(s)
SPECTRUM cigarettes between
Intervention Description
Participants will be assigned one of the nicotine concentrations of a SPECTRUM cigarette. They will complete a cigarette purchase task and make real purchases for the next week. Participants will return and make purchases again, repeating 4 times.
Primary Outcome Measure Information:
Title
Estimated Cigarettes Taken at Free Price Derived From the Cigarette Purchase Task
Description
The Cigarette Purchase Task is a behavioral economic measure of abuse liability that consists of a series of hypothetical questions asking participants to indicate how many cigarettes they would purchase for their own consumption across a range of cigarette prices. Participants smoked one cigarette and then were asked to report how many cigarettes they would smoke within a 24 hour period at the following prices: $0.00 (free), $0.01, $0.05, $0.10, $0.25, $0.50, $1, $2, $5, $10, $25, $50, $100, $200. Nonlinear regression was then used to estimate the number of cigarettes participants would take when they were free using the equation by Koffarnus et al. (2015; doi:10.1037/pha0000045). The outcome is the logarithmically transformed number of cigarettes.
Time Frame
10 minutes after cigarette administration
Title
Change in Blood Nicotine Content Over the Course of the Session
Description
For participants in the single arm only, blood will be collected throughout each session and analyzed for nicotine content. The change in blood nicotine content over the course of the session will be compared among the six sessions where different cigarettes were administered. Blood nicotine (expressed in ng/mL) at minute 0 was subtracted from blood nicotine at minutes 10, 15, 20, 30, 45, and 60 to yield a change in blood nicotine (negative values were truncated to 0) at each of the time points. Using these change in blood nicotine values, we calculated Area Under the Curve (AUC) via the trapezoidal rule, which resulted in a singular number (total change in blood nicotine over the course of each experimental session) in our primary outcome measure.
Time Frame
Each session (6 sessions total) with at least 2 days between each session.
Title
Experimental Marketplace Purchases
Description
In all arms except the single arm, measures of quantities of experimental cigarettes and other nicotine products will be obtained.
Time Frame
Sessions 2-5 with each session conducted one week apart (for 4 weeks total)

10. Eligibility

Sex
All
Minimum Age & Unit of Time
18 Years
Maximum Age & Unit of Time
65 Years
Accepts Healthy Volunteers
Accepts Healthy Volunteers
Eligibility Criteria
Inclusion Criteria: smoke at least 5 cigarettes per day have a breath carbon monoxide (CO) level of at least 10 ppm at intake no immediate plans to quit smoking. Exclusion Criteria: pregnant, lactating, plans to become pregnant weigh more than 110lbs (experiment 1 only) have plans to move out of the area during the course of the experiment To see if you are eligible, use the following confidential link: http://vtcri.info/arrcclinicaltrials
Overall Study Officials:
First Name & Middle Initial & Last Name & Degree
Warren K Bickel, PhD
Organizational Affiliation
Virginia Polytechnic Institute and State University
Official's Role
Principal Investigator
Facility Information:
Facility Name
Fralin Biomedical Research Institute at VTC
City
Roanoke
State/Province
Virginia
ZIP/Postal Code
24016
Country
United States

12. IPD Sharing Statement

Learn more about this trial

Abuse Liability of Reduced Nicotine Content Cigarettes Within a Complex Tobacco Marketplace

We'll reach out to this number within 24 hrs